Menu

Blog

Page 156

Apr 5, 2024

Peer inside remnants of an 800-year-old supernova and see a ‘zombie’ star

Posted by in category: cosmology

Baby, you’re a firework.

Apr 5, 2024

Document (2).Pdf

Posted by in category: futurism

Eliminating mistakes about eliminative materialism.


Shared with Dropbox.

Apr 5, 2024

2312.09257–3.pdf

Posted by in category: robotics/AI

Brain inspired machine intelligence.


Shared with Dropbox.

Apr 5, 2024

Paper page — Red Teaming GPT-4V: Are GPT-4V Safe Against Uni/Multi-Modal Jailbreak Attacks?

Posted by in category: futurism

Red Teaming GPT-4V

Are GPT-4V safe against uni/multi-modal jailbreak attacks?


Join the discussion on this paper page.

Apr 5, 2024

BREAKING: TESLA Robotaxi Unveil in August!! w/ Meet Kevin

Posted by in category: futurism

Get Free TESLA Milestone Tables My website: https://www.TeslaInvestor.comCheck out 15+ modules of resources for the $TSLA InvestorJoin this channel or Patreo…

Apr 5, 2024

Cicada Map Shows States Where Trillions of Bugs Will Emerge

Posted by in category: futurism

Two populations will appear at the same time, carpeting an area from southern Wisconsin to the Carolinas.

Apr 5, 2024

Revitalizing Vision: Metabolome Rejuvenation Can Slow Retinal Degeneration

Posted by in categories: bioengineering, biotech/medical, genetics, life extension

Gene therapy may be the best hope for curing retinitis pigmentosa (RP), an inherited condition that usually leads to severe vision loss and blinds 1.5 million people worldwide.

But there’s a huge obstacle: RP can be caused by mutations in over 80 different genes. To treat most RP patients with gene therapy, researchers would have to create a therapy for each gene—a nearly impractical task using current gene therapy strategies.

A more universal treatment may be forthcoming. Using CRISPR-based genome engineering, scientists at Columbia University Vagelos College of Physicians and Surgeons are designing a gene therapy with the potential to treat RP patients regardless of the underlying genetic defect.

Apr 5, 2024

Human neuron model paves the way for new Alzheimer’s therapies

Posted by in categories: biotech/medical, neuroscience

Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain—a process that drives cognitive decline in Alzheimer’s disease and frontotemporal dementia. This new model has led to the identification of novel therapeutic targets that could potentially block tau spread.

Apr 5, 2024

Efficient Cell Separation for Cell Therapy and Beyond

Posted by in categories: biotech/medical, robotics/AI

An automated counterflow centrifugation–based technology outperforms manual peripheral blood mononuclear cell (PBMC) isolation.

Apr 5, 2024

This new solid-state battery cell claims to set industry records, could offer over 1,300 mile range

Posted by in categories: energy, transportation

A solid-state battery developer in China has unveiled a new cell that could help change the game for electric mobility. Tailan New Energy’s vehicle-grade all-solid-state lithium batteries offer energy density twice that of other cells in the segment, empowering the Chinese battery maker to hail the cells as a record-setter in the industry.

Tailan New Energy, aka Talent New Energy, is a private solid-state battery developer founded in Beijing, China, in 2018, where it remains headquartered in its research.

Per its website, it was “co-founded by lithium battery R&D experts and a senior domestic industrialization team, focusing on the technological development and industrialization of new solid-state lithium batteries and key lithium battery materials.”

Page 156 of 11,091First153154155156157158159160Last